Address
6420 Levit Green Blvd
Houston, TX 77021
United States of America (the)
Phone
N/A
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
28
First IPO Date
August 03, 2026
| Name | Title | Pay | Year Born |
| Marc H. Hedrick | President, CEO & Director | 934,244 | 1963 |
| Andrew J. Sims | VP & CFO | 556,737 | 1973 |
| Russell W. Bradley | President & GM of CNSide Diagnostics, LLC | 0 | 1964 |
| Russ Havranek | Executive Vice President of Commercial and Corporate Strategy | 0 | N/A |
| Desiree Smith | Corporate Controller | 0 | 1964 |
| Eric J. Daniels | Chief Development Officer | 0 | 1973 |
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.